CD8A and COVID-19: Similar results were detected in our study with patients in the acute phase of COVID-19, which showed an increase in NK cells and CD4+ T cells (20–30 days), but a decrease in CD8+ T cells up to 10 days and between 20 and 30 days from the onset of symptoms.